Transgenic mice expressing constitutively active akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma

In Vivo

Volumn 23, Issue 5, 2009, Pages 653-660

  Moral, Marta ^a   Segrelles, Carmen ^a   Martínez Cruz, Ana Belén ^a   Lorz, Corina ^a   Santos, Mirentxu ^a   García Escudero, Ramón ^a   Lu, Jerry ^b   Buitrago, Agueda ^a   Costa, Clotilde ^a   Saiz, Cristina ^a   Ariza, José M ^a   Dueñas, Marta ^a   Rodriguez Peralto, Jose L ^c   Martinez Tello, Francisco J ^c   Rodriguez Pinilla, Maria ^d   Sanchez Cespedes, Montserrat ^d   DiGiovanni, John ^b   Paramio, Jesús M ^a  

^a Cutaneous Diseases Modeling Unit   (Spain)

^b UNIVERSITY OF TEXAS   (United States)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Akt; Cancer; HNSCC; KLF4; Microarray; Transgenic mouse

Indexed keywords

BIOLOGICAL MARKER; KRUPPEL LIKE FACTOR 4; PROTEIN KINASE B;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; FUNCTIONAL GENOMICS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; KERATINOCYTE; MOUSE; MOUTH MUCOSA; NONHUMAN; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TRANSGENIC MOUSE;

EID: 70350059412     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Neville BW and Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin 52(4): 195-215, 2002.
2. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK and Ang KK: Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med 354(6): 567-578, 2006. (Pubitemid 43209104)
3. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J and Cooper J: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22): 2091-2098, 2003. (Pubitemid 37464533)
4. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maitre A, Pajak TF, Poulsen MG, O'Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, and Pignon JP: Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368(9538): 843-854, 2006. (Pubitemid 44292807)
5. Baselga J, Trigo JM, Bourhis J, Tortochaux J, Cortes-Funes H, Hitt R, Gascon P, Amellal N, Harstrick A and Eckardt A: Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 23(24): 5568-5577, 2005.
6. Lu SL, Herrington H and Wang XJ: Mouse models for human head and neck squamous cell carcinomas. Head Neck 28(10): 945-954, 2006. (Pubitemid 44497871)
7. Mao L, Hong WK and Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell 5(4): 311-316, 2004.
8. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V and Gutkind JS: Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol, 2008.
9. Perez-Ordonez B, Beauchemin M and Jordan RC: Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59(5): 445-453, 2006.
10. Jimeno A, Kulesza P, Wheelhouse J, Chan A, Zhang X, Kincaid E, Chen R, Clark DP, Forastiere A and Hidalgo M: Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy. Br J Cancer 96(6): 952-959, 2007.
11. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2(7): 489-501, 2002. (Pubitemid 37328931)
12. Luo J, Manning BD and Cantley LC: Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4(4): 257-262, 2003. (Pubitemid 37329790)
13. Amornphimoltham P, Sriuranpong V, Patel V, Benavides F, Conti CJ, Sauk J, Sausville EA, Molinolo AA and Gutkind JS: Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 10(12 Pt 1): 4029-4037, 2004.
14. Segrelles C, Moral M, Lara MF, Ruiz S, Santos M, Leis H, Garcia-Escudero R, Martinez-Cruz AB, Martinez-Palacio J, Hernandez P, Ballestin C and Paramio JM: Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 25(8): 1174-1185, 2006. (Pubitemid 43297932)
15. Pedrero JM, Carracedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS and Gonzalez MV: Frequent genetic and biochemical alterations of the PI3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int J Cancer 114(2): 242-248, 2005. (Pubitemid 40194293)
16. Moral M and Paramio JM: Akt pathway as a target for therapeutic intervention in HNSCC. Histol Histopathol 23(10): 1269-1278, 2008.
17. Segrelles C, Lu J, Hammann B, Santos M, Moral M, Cascallana JL, Lara MF, Rho O, Carbajal S, Traag J, Beltran L, Martinez-Cruz AB, Garcia-Escudero R, Lorz C, Ruiz S, Bravo A, Paramio JM and DiGiovanni J: Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. Cancer Res 67(22): 10879-10888, 2007.
18. Segrelles C, Moral M, Lorz C, Santos M, Lu J, Cascallana JL, Lara MF, Carbajal S, Martinez-Cruz AB, Garcia-Escudero R, Beltran L, Segovia JC, Bravo A, Digiovanni J and Paramio JM: Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signaling. Mol Biol Cell 19(1): 137-149, 2008. (Pubitemid 351186140)
19. Moral M, Segrelles C, Lara MF, Martinez-Cruz AB, Lorz C, Santos M, Garcia-Escudero R, Lu J, Kiguchi K, Buitrago A, Costa C, Saiz C, Rodriguez-Peralto JL, Martinez-Tello FJ, Rodriguez-Pinilla M, Sanchez-Cespedes M, Garin M, Grande T, Bravo A, DiGiovanni J and Paramio JM: Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma. Cancer Res 69(3): 1099-1108, 2009.
20. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M and Berns A: Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29(4): 418-425, 2001. (Pubitemid 34326692)
21. Martinez-Cruz AB, Santos M, Lara MF, Segrelles C, Ruiz S, Moral M, Lorz C, Garcia-Escudero R and Paramio JM: Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors. Cancer Res 68(3): 683-692, 2008. (Pubitemid 351206743)
22. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2): 249-264, 2003.
23. Vaquerizas JM, Conde L, Yankilevich P, Cabezon A, Minguez P, Diaz-Uriarte R, Al-Shahrour F, Herrero J and Dopazo J: GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. Nucleic Acids Res 33(Web Server issue): W616-620, 2005.
24. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V and Quackenbush J: TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34(2): 374-378, 2003.
25. Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Ballestin C, Diez A, Sanchez-Verde L, Alameda F, and Sanchez-Cespedes M: Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer. Clin Cancer Res 10(24): 8486-8492, 2004.
26. Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Sanchez-Verde L, Alameda F, Ballestin C and Sanchez-Cespedes M: β-Catenin, NF-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters. Cancer Lett 230(1): 141-148, 2005.
27. Molinolo AA, Hewitt SM, Amornphimoltham P, Keelawat S, Rangdaeng S, Meneses Garcia A, Raimondi AR, Jufe R, Itoiz M, Gao Y, Saranath D, Kaleebi GS, Yoo GH, Leak L, Myers EM, Shintani S, Wong D, Massey HD, Yeudall WA, Lonardo F, Ensley J and Gutkind JS: Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res 13(17): 4964-4973, 2007.
28. McConnell BB, Ghaleb AM, Nandan MO and Yang VW: The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29(6): 549-557, 2007.
29. Rowland BD and Peeper DS: KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6(1): 11-23, 2006.
30. Foster KW, Ren S, Louro ID, Lobo-Ruppert SM, McKie-Bell P, Grizzle W, Hayes MR, Broker TR, Chow LT and Ruppert JM: Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ 10(6): 423-434, 1999.
31. Huang CC, Liu Z, Li X, Bailey SK, Nail CD, Foster KW, Frost AR, Ruppert JM and Lobo-Ruppert SM: KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol Ther 4(12): 1401-1408, 2005. (Pubitemid 43131188)
32. Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson AJ, Kudlow JE, Lobo-Ruppert SM and Ruppert JM: Induction of KLF4 in basal keratinocytes blocks the proliferation- differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24(9): 1491-1500, 2005. (Pubitemid 40396079)
33. Segre JA, Bauer C and Fuchs E: Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 22(4): 356-360, 1999. (Pubitemid 29369526)
34. Rowland BD, Bernards R and Peeper DS: The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7(11): 1074-1082, 2005.
35. Leis H, Segrelles C, Ruiz S, Santos M and Paramio JM: Expression, localization, and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis. Mol Carcinog 35(4): 180-185, 2002. (Pubitemid 36056712)
36. Amornphimoltham P, Patel V, Sodhi A, Nikitakis NG, Sauk JJ, Sausville EA, Molinolo AA and Gutkind JS: Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Cancer Res 65(21): 9953-9961, 2005. (Pubitemid 41541476)
37. Wei D, Kanai M, Huang S and Xie K: Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27(1): 23-31, 2006. (Pubitemid 43032979)
38. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S and Xie K: Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 65(7): 2746-2754, 2005. (Pubitemid 40490076)
39. Ghaleb AM, McConnell BB, Nandan MO, Katz JP, Kaestner KH and Yang VW: Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res 67(15): 7147-7154, 2007.
40. Jiang W, Lobo-Ruppert SM and Ruppert JM: Bad things happen in the basal layer: KLF4 and squamous cell carcinoma. Cancer Biol Ther 7(5): 783-785, 2008. (Pubitemid 351847018)
41. Ehlermann J, Pfisterer P and Schorle H: Dynamic expression of Kruppel-like factor 4 (Klf4), a target of transcription factor AP-2alpha during murine mid-embryogenesis. Anat Rec A Discov Mol Cell Evol Biol 273(2): 677-680, 2003.
42. Behr R and Kaestner KH: Developmental and cell type-specific expression of the zinc finger transcription factor Kruppel-like factor 4 (Klf4) in postnatal mouse testis. Mech Dev 115(1-2): 167-169, 2002.
43. Yoon HS, Ghaleb AM, Nandan MO, Hisamuddin IM, Dalton WB and Yang VW: Kruppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage. Oncogene 24(25): 4017-4025, 2005.
44. Yoon HS and Yang VW: Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem 279(6): 5035-5041, 2004.